IL143514A0 - METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ3 - Google Patents

METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ3

Info

Publication number
IL143514A0
IL143514A0 IL14351499A IL14351499A IL143514A0 IL 143514 A0 IL143514 A0 IL 143514A0 IL 14351499 A IL14351499 A IL 14351499A IL 14351499 A IL14351499 A IL 14351499A IL 143514 A0 IL143514 A0 IL 143514A0
Authority
IL
Israel
Prior art keywords
methods
compositions useful
vitronectin receptor
targeting activated
receptor αvβ3
Prior art date
Application number
IL14351499A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL143514A0 publication Critical patent/IL143514A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
IL14351499A 1998-12-04 1999-12-03 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ3 IL143514A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11095098P 1998-12-04 1998-12-04
US14545899P 1999-07-23 1999-07-23
PCT/EP1999/009460 WO2000034780A2 (en) 1998-12-04 1999-12-03 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3?

Publications (1)

Publication Number Publication Date
IL143514A0 true IL143514A0 (en) 2002-04-21

Family

ID=26808539

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14351499A IL143514A0 (en) 1998-12-04 1999-12-03 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ3

Country Status (8)

Country Link
US (1) US20040005550A1 (ja)
EP (1) EP1135688A2 (ja)
JP (1) JP2002532685A (ja)
AU (1) AU768329B2 (ja)
CA (1) CA2351452A1 (ja)
IL (1) IL143514A0 (ja)
NZ (1) NZ511937A (ja)
WO (1) WO2000034780A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7538195B2 (en) 2002-06-14 2009-05-26 Immunogen Inc. Anti-IGF-I receptor antibody
US8034904B2 (en) 2002-06-14 2011-10-11 Immunogen Inc. Anti-IGF-I receptor antibody
KR20070001883A (ko) * 2003-12-08 2007-01-04 이뮤노젠 아이엔씨 항-아이쥐에프-아이 수용체 항체
US7271245B2 (en) * 2004-02-13 2007-09-18 The Scripps Research Institute Methods and compositions for inhibition of metastasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578704A (en) * 1992-04-03 1996-11-26 Genentech, Inc. Antibody to osteoclast alphavbeta3 ntegrin
WO1994017832A1 (en) * 1993-02-09 1994-08-18 The Scripps Research Institute Targeting and delivery of genes and antiviral agents into cells by the adenovirus penton
US6590079B2 (en) * 1997-01-30 2003-07-08 Ixsys, Incorporated Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same

Also Published As

Publication number Publication date
EP1135688A2 (en) 2001-09-26
WO2000034780A2 (en) 2000-06-15
AU1780100A (en) 2000-06-26
US20040005550A1 (en) 2004-01-08
CA2351452A1 (en) 2000-06-15
NZ511937A (en) 2004-02-27
WO2000034780A3 (en) 2000-10-19
JP2002532685A (ja) 2002-10-02
WO2000034780A8 (en) 2001-09-13
AU768329B2 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
EP1176948A4 (en) COMPOSITIONS AND METHODS
IL144508A0 (en) Compositions and methods for use in targeting vascular destruction
GB9920678D0 (en) Sanitising compositions and methods
PL342881A1 (en) Vitronectin receptor antagonists
GB0009759D0 (en) Rail support structures and geosynthetics
EP1075184A4 (en) ACTIVE VACCINATION COMPOSITIONS AND METHODS
PL353214A1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors
IL143514A0 (en) METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ3
HK1049667A1 (zh) 整聯蛋白αVβ3的抑制劑
GC0000203A (en) Vitronectin receptor antagonists
TW424891U (en) Holding and fixing structure
GB9922135D0 (en) Compositions and uses
GB0318113D0 (en) ›-Secretase enzyme compositions and methods
HUP0201729A2 (en) Inhibitors of the integrin alpha v betha 6
PL346157A1 (en) Vitronectin receptor antagonists
HK1049666A1 (zh) 新型整合蛋白αVβ3抑制劑
HK1047238A1 (zh) 抗肥胖劑
EP1071325A4 (en) COMPOSITIONS AND METHODS FOR SPECIFIC VACCINATION OF THE ANTIGEN
EP0928194A4 (en) COMPOSITIONS AND METHODS FOR ADMINISTERING INTEGRIN RECEPTOR ANTAGONISTS
EP1234074A4 (en) FASTENING ELEMENT FOR RAIL CLAMP
GB9916503D0 (en) Compositions and methods
GB9916506D0 (en) Compositions and methods
GB9921747D0 (en) Compositions and methods
GB9928549D0 (en) Compositions and methods
EG22092A (en) Sanitising compositions and methods